scispace - formally typeset
Journal ArticleDOI

Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells.

Reads0
Chats0
TLDR
In this paper, the role of Glutathione peroxidase 4 (GPX4) and mammalian target of rapamycin (mTOR) in regulation of lung cancer cells response to Lapatinib (Lap).
About
This article is published in Biochemical and Biophysical Research Communications.The article was published on 2021-06-20. It has received 30 citations till now. The article focuses on the topics: Lapatinib & Epidermal growth factor receptor.

read more

Citations
More filters
Journal ArticleDOI

System Xc −/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

TL;DR: This review aims to present the current understanding of the mechanism of ferroptosis based on the System Xc −/GSH/GPX4 axis in the treatment of drug-resistant solid tumors.
Journal ArticleDOI

SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer

TL;DR: In this paper, SIRT6 silencing overcomes sorafenib resistance by promoting ferroptosis, which is a novel form of cell death, in gastric cancer.
Journal ArticleDOI

CircDTL Functions as an Oncogene and Regulates Both Apoptosis and Ferroptosis in Non-small Cell Lung Cancer Cells.

TL;DR: In this article, the authors investigated the role of circRNA in the tumorigenesis of non-small cell lung cancer (NSCLC) using RT-PCR and showed that circDTL upregulated and acted as an oncogene in NSCLC cells.
Journal ArticleDOI

Regulatory pathways and drugs associated with ferroptosis in tumors

TL;DR: In this paper , the authors reviewed the latest studies on the regulation of ferroptosis in tumor cells and introduced the tumor-related signaling pathways of the FerroPTosis process.
Journal ArticleDOI

The role of ferroptosis in lung cancer.

TL;DR: In this article, the authors summarized the core mechanism and regulatory network of ferroptosis in lung cancer cells, and highlighted the induction-related tumor therapies, which may provide new insights for targeted lung cancer therapy.
References
More filters
Journal ArticleDOI

New driver mutations in non-small-cell lung cancer

TL;DR: Subsets defined by so-called driver mutations in ALK, HER2, BRAF, PIK3CA, AKT1, MAP2K1, and MET are reviewed.
Journal ArticleDOI

Global Epidemiology of Lung Cancer

TL;DR: The evidence on lung cancer epidemiology, including data of international scope with comparisons of economically, socially, and biologically different patient groups is reviewed, including a discussion on the epidemiologic characteristics of special groups including women and nonsmokers.
Journal ArticleDOI

Role of GPX4 in ferroptosis and its pharmacological implication

TL;DR: An overview of what is known about ferroptosis today and its future translational impact is provided to provide an overview of the rapidly growing interest in this form of cell death.
Related Papers (5)